Why the Allegra (ASX:AMT) share price rocketed up 137% today

The Allegra (ASX: AMT) share price rocketed up today on positive testing results for its revised spinal cage device. Let’s take a look.
The post Why the Allegra (ASX:AMT) share price rocketed up 137% today appeared first on The Motley Fool Australia. –

Man looking excitedly at ASX share price gains on computer screen against backdrop of streamers

The Allegra Orthopaedics Ltd (ASX: AMT) share price shot up 137.5% today on positive test results. The company advised that testing of its revised spinal cage device showed significant improvement in strength, compared to its previous design.

The Allegra share price jumped as high as 61 cents at the news today, before retreating to close at the current price of 44 cents.

About the test results

The spinal cage device is Allegra’s flagship innovation project, a unique biodegradable cervical fusion device to be used as a human bone substitute.

The medical device company has engaged an accredited testing facility in the United States to confirm the effectiveness of a revised design to the device. Today’s results showed a significant improvement in strength. Specifically, the revised device has a compressive strength of  60kN. This is significantly above human physiological load (1.2kN), and sheep physiological load (3-4kN).

It is also double the compressive strength of the previous design, and above the 95th percentile for published data on FDA approved cages.

Allegra said the same facility conducted dynamic compressive testing to determine the fatigue life of the spinal cage. The testing passed the regulatory-required 5 million dynamic cycles without any signs of fracture or failure.

Due to these positive results, Allegra will now go ahead with the new design. The company plans to start a pilot animal study in January 2021 in Australia. This will be a confirmatory study to be followed by a large animal study, as per FDA requirements.

Today’s announcement marks one year since the company started its initial preclinical large animal study.

The Allegra share price in 2020

The Allegra share price spiked in July by as much as 500% to 53 cents after it acquired Sr-HT-Gahnite patents from the University of Sydney. This is the material used for its spinal cage device.

After today, the Allegra share price is closing in on that high, and currently commands a market cap of $21 million.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

Motley Fool contributor Eddy Sunarto has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Allegra (ASX:AMT) share price rocketed up 137% today appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!